BCV
ABBV icon

Banque Cantonale Vaudoise’s AbbVie ABBV Stock Holding History

Banque Cantonale Vaudoise’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.5M Buy
94,191
+526
+0.6% +$117K 0.77% 18
2025
Q4 		$21.4M Buy
93,665
+18,362
+24% +$4.18M 0.76% 20
2025
Q3 		$17.4M Sell
75,303
-1,293
-2% -$263K 0.65% 24
2025
Q2 		$14.2M Buy
76,596
+7,127
+10% +$1.32M 0.58% 27
2025
Q1 		$14.6M Buy
+69,469
New +$13.5M 0.64% 20
2024
Q3 		$9.56M Buy
48,408
+4,650
+11% +$868K 0.39% 53
2024
Q2 		$7.5M Sell
43,758
-8,486
-16% -$1.41M 0.3% 56
2024
Q1 		$9.51M Buy
52,244
+8,122
+18% +$1.4M 0.37% 45
2023
Q4 		$6.84M Sell
44,122
-10,473
-19% -$1.53M 0.3% 67
2023
Q3 		$8.14M Sell
54,595
-2,675
-5% -$393K 0.41% 45
2023
Q2 		$7.72M Buy
57,270
+7,289
+15% +$1.07M 0.36% 55
2023
Q1 		$7.97M Buy
49,981
+158
+0.3% +$24.2K 0.39% 47
2022
Q4 		$8.05M Sell
49,823
-10,329
-17% -$1.58M 0.42% 41
2022
Q3 		$8.07M Sell
60,152
-6,216
-9% -$892K 0.46% 36
2022
Q2 		$10.2M Buy
66,368
+7,235
+12% +$1.11M 0.53% 32
2022
Q1 		$9.58M Buy
59,133
+4,667
+9% +$678K 0.41% 42
2021
Q4 		$7.38M Sell
54,466
-10,069
-16% -$1.19M 0.29% 60
2021
Q3 		$6.96M Buy
64,535
+26,359
+69% +$3.01M 0.3% 60
2021
Q2 		$4.3M Sell
38,176
-21,874
-36% -$2.46M 0.19% 105
2021
Q1 		$6.5M Sell
60,050
-14,199
-19% -$1.52M 0.33% 52
2020
Q4 		$7.96M Sell
74,249
-2,895
-4% -$278K 0.44% 44
2020
Q3 		$6.76M Buy
77,144
+8,554
+12% +$805K 0.43% 46
2020
Q2 		$6.73M Buy
68,590
+15,258
+29% +$1.34M 0.49% 36
2020
Q1 		$4.06M Buy
53,332
+5,200
+11% +$443K 0.34% 54
2019
Q4 		$4.26M Buy
+48,132
New +$4M 0.29% 64

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Banque Cantonale Vaudoise's ABBV Position: Q1 2026 in Review

Banque Cantonale Vaudoise increased its AbbVie (ABBV) stake by 0.56% in Q1 2026, buying an estimated $117K and bringing the position to 94,191 shares worth $20.5M. The position accounts for 0.77% of the portfolio, ranked #18.

Banque Cantonale Vaudoise first reported a position in ABBV in Q4 2019 and has held it in 25 quarters since. The position peaked at $21.4M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Banque Cantonale Vaudoise held 94,191 shares of AbbVie worth $20.5M as of Q1 2026.
  • Banque Cantonale Vaudoise bought 526 AbbVie shares in Q1 2026, an estimated $117K.
  • AbbVie made up 0.77% of Banque Cantonale Vaudoise's portfolio in Q1 2026, its #18 holding.
  • Banque Cantonale Vaudoise first reported a position in AbbVie in Q4 2019 and has held it in 25 quarters since.
  • Banque Cantonale Vaudoise's AbbVie position peaked at $21.4M in Q4 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2026, filed 20 Apr 2026.